PROMOTION
COMBINING SCITON’S HALO™ AND BBL™ TO MAXIMIZE BENEFITS
Unparalleled results with the world’s first hybrid fractional laser and reversing skin ageing at the genetic level with BBL™
F
CHRISTOPHER W. ROBB, MD, PHD is co-founder of Skin & Allergy Center, Tennessee, US;
ANTONIO CAMPO, MD, PHD is founder of Campo-Optimage, Barcelona, Spain
OR YEARS, DOCTORS have been faced with choosing between an ablative or non- ablative laser for their practice. Ablative
fractional resurfacing is a well- established treatment that achieves notable results by vaporizing aged tissue while causing significant patient downtime. Alternatively, non- ablative fractional resurfacing treatments tend to heal quicker but do not always meet high patient and physician expectations. In 2014, Sciton shifted the landscape of resurfacing by introducing Halo™, a Hybrid Fractional Laser that delivers both non-ablative (1470 nm) and ablative (2940 nm) wavelengths to the same microscopic treatment zone. Halo produces the impactful results of an ablative modality while generating the shorter downtimes that patients have come to expect from non-ablative lasers.
60
The Halo device The Halo treatment speaks for itself, according to Dr. Chris W. Robb, MD, PhD, the co-founder of Skin & Allergy Center in Tennessee, USA. ‘I have never marketed Halo. I don’t have to. I have an average patient population for a Dermatologist: I see 30–40 patients a day with a mix of surgical and general Dermatology. Halo has dramatic results, especially as it pertains to
January/February 2016 |
prime-journal.com
texture, dyschromia and UV signature, which gives an improved light reflex. This is the so called ‘Halo glow’. Patients’ friends notice how fresh they are, comment on it and the next thing you know I have another one or two Halo customers.” As a Key Opinion Leader in the field of Aesthetic Dermatology in the USA, Dr. Robb was instrumental in the development and launch of Halo. His clinic is a national center for Halo training and treatments where patients come from around the country for the procedure.
Combining Halo with BroadBand Light Recently, Dr. Robb began treating patients with the combination of Halo and BroadBand Light (BBL)™ to maximize benefits. According to Dr. Robb: ‘These treatments have
almost anyone can be a candidate, ‘From the patient with several brown lesions that would benefit from a full-field BBL, to the fair- skinned patient who would benefit from BBL just to control erythema post Halo — every patient can derive some benefit from this combination treatment. This brings two home run treatment protocols together with minimal downtime.’ One of the many modules Sciton
offers on its platform, BBL treats a wide variety of indications. This includes vascular lesions, acne, texture, hair, and pigmented lesions producing immediate results. With user-friendly features and exceptional return-on-investment, BBL is the most complete and versatile BroadBand Light system in its class. The large 15 x 45 mm spot size, integrated cooling, dual lamp, and rapid repetition rate
“ The Forever Young BBL™ treatment protocol supporting anti-ageing and the reversal of skin damage gave me a tool that no other company was able to provide with clinical evidence.”
different purposes. Combining full- field BBL with Halo improves the downtime of BBL and adds to the uniqueness of Halo with its textural and reflectivity changes, changes in the mid-range UV signature and dramatic improvements in fine wrinkles and pores.’ Dr. Robb comments on how
enable users to perform an efficient and efficacious treatment. When asked why he originally chose Sciton’s BBL versus the competition, Dr. Robb notes it was an easy decision, stating, ‘I had read the Stanford study1
(www.
foreveryoungbbl.com/clinical_ evidence.php) and found the
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68